Header cover image

Ugandan (ALSIUG) Pharma Industry Analysis

UpdatedApr 25, 2024
DataAggregated Company Financials
Companies1
  • 7D0%
  • 3M1.0%
  • 1Y-24.3%
  • YTDn/a

Over the last 7 days, the Pharma industry has remained flat. Unfortunately though, the industry is down 23% over the past 12 months.

Industry Valuation and Performance

Has the Ugandan Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Apr 2024USh193.6bUSh221.5bUSh19.0b10.2x10.2x0.9x
Sun, 24 Mar 2024USh191.7bUSh221.5bUSh19.0b10.1x10.1x0.9x
Tue, 20 Feb 2024USh191.7bUSh221.5bUSh19.0b10.1x10.1x0.9x
Thu, 18 Jan 2024USh191.7bUSh221.5bUSh19.0b10.1x10.1x0.9x
Sat, 16 Dec 2023USh191.7bUSh221.5bUSh19.0b10.1x10.1x0.9x
Mon, 13 Nov 2023USh255.6bUSh221.5bUSh19.0b13.5x13.5x1.2x
Wed, 11 Oct 2023USh237.4bUSh221.5bUSh19.0b12.5x12.5x1.1x
Fri, 08 Sep 2023USh255.6bUSh221.5bUSh19.0b13.5x13.5x1.2x
Sun, 06 Aug 2023USh255.6bUSh221.5bUSh19.0b13.5x13.5x1.2x
Tue, 04 Jul 2023USh255.6bUSh221.5bUSh19.0b13.5x13.5x1.2x
Thu, 01 Jun 2023USh255.6bUSh267.4bUSh24.1b10.6x10.6x1x
Sat, 29 Apr 2023USh255.6bUSh267.4bUSh24.1b10.6x10.6x1x
Mon, 27 Mar 2023USh219.1bUSh267.4bUSh24.1b9.1x9.1x0.8x
Wed, 22 Feb 2023USh219.1bUSh267.4bUSh24.1b9.1x9.1x0.8x
Fri, 20 Jan 2023USh219.1bUSh0USh0n/an/an/a
Sun, 18 Dec 2022USh219.1bUSh0USh0n/an/an/a
Tue, 15 Nov 2022USh237.4bUSh0USh0n/an/an/a
Thu, 13 Oct 2022USh237.4bUSh0USh0n/an/an/a
Sat, 10 Sep 2022USh255.6bUSh284.5b-USh10,538,243,000.00n/a-24.3x0.9x
Mon, 08 Aug 2022USh255.6bUSh284.5b-USh10,538,243,000.00n/a-24.3x0.9x
Wed, 06 Jul 2022USh252.0bUSh284.5b-USh10,538,243,000.00n/a-23.9x0.9x
Fri, 03 Jun 2022USh255.6bUSh284.5b-USh10,538,243,000.00n/a-24.3x0.9x
Sun, 01 May 2022USh321.4bUSh284.5b-USh10,538,243,000.00n/a-30.5x1.1x
Tue, 29 Mar 2022USh328.7bUSh284.5b-USh10,538,243,000.00n/a-31.2x1.2x
Thu, 24 Feb 2022USh340.4bUSh284.5b-USh10,538,243,000.00n/a-32.3x1.2x
Sat, 22 Jan 2022USh336.0bUSh284.5b-USh10,538,243,000.00n/a-31.9x1.2x
Mon, 20 Dec 2021USh343.3bUSh284.5b-USh10,538,243,000.00n/a-32.6x1.2x
Wed, 17 Nov 2021USh343.3bUSh284.5b-USh10,538,243,000.00n/a-32.6x1.2x
Fri, 15 Oct 2021USh343.3bUSh284.5b-USh10,538,243,000.00n/a-32.6x1.2x
Sun, 12 Sep 2021USh330.9bUSh284.5b-USh10,538,243,000.00n/a-31.4x1.2x
Tue, 10 Aug 2021USh346.9bUSh192.7b-USh23,072,863,000.00n/a-15x1.8x
Mon, 03 May 2021USh346.9bUSh192.7b-USh23,072,863,000.00n/a-15x1.8x
Price to Earnings Ratio

-15x


Total Market Cap: USh346.9bTotal Earnings: -USh23,072,863,000.00Total Revenue: USh192.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Ugandan Pharma Industry Price to Earnings3Y Average -7.7x202220232024
Current Industry PE
    There is only one company in the Ugandan Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • Total earnings for the Pharmaceuticals industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 4.8% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Comparison

How does Ugandan Pharma compare with similar industries?

UG Market0.65%
Healthcare0%
Pharma0%
Pharma0%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News